Patent details

88263 Product Name: ODRIK (Trandolapril)

Basic Information

Publication number:
88263
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP821120078
Legal Status:
Expired
Application number:
88263
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
568/93/01/0138
Marketing Authorization Type:
Marketing Authorization Date:
20/01/1993
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
NL-17687
Marketing Authorization Type:
Marketing Authorization Date:
19/02/1992
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
12/05/1993
First Marketing Authorization date:
19/02/1992
Grant date:
03/02/1994
Activation date:
24/12/2002
Publication date:
03/02/1994
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
19/02/2007
SPC Extension Expiration:
19/02/2007
Rejection date:
Withdrawal date:

Owner

From:
01/09/2004
 
 

Name:
ABBOTT IRELAND
Address:
CLARENDON HOUSE, CHURCH STREET, HAMILTON 5-31 BERMUDA, Ireland (IE)

History of Owners

From:
01/09/2004
To:
01/09/2004

Name:
AVENTIS PHARMA S.A.
Address:
AVENUE RAYMOND ARON 20, 92160, ANTONY CEDEX FRANCE, France (FR)

From:
07/03/2001
To:
31/08/2004

Name:
AVENTIS PHARMA DEUTSCHLAND GMBH
Address:
BRÜNINGSTRASSE 50, 65929, FRANKFURT, Germany (DE)

From:
12/05/1993
To:
06/03/2001

Name:
HOECHST AKTIENGESELLSCHAFT
Address:
BrÜningstrasse 50, 65929 Frankfurt am Main, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
12/05/1993
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:
Filing date Document type Number of pages